Avalo Therapeutics Inc
(AVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,073 | -40,053 | 11,870 | -16,472 | -10,490 |
| Depreciation Amortization | 5,440 | 6,717 | 563 | 27 | 24 |
| Income taxes - deferred | 17 | -17 | -833 | N/A | N/A |
| Accounts receivable | 1,658 | -223 | -247 | -133 | N/A |
| Accounts payable and accrued liabilities | 1,019 | 83 | 96 | 332 | -269 |
| Other Working Capital | -2,023 | 8,708 | -199 | 14 | -385 |
| Other Operating Activity | -9,173 | 21,656 | 1,329 | 1,658 | 957 |
| Operating Cash Flow | $-19,134 | $-3,128 | $12,579 | $-14,573 | $-10,163 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -262 | -564 | -23 | -35 | -20 |
| Net Acquisitions | N/A | 0 | -18,889 | N/A | N/A |
| Other Investing Activity | -181 | 1,430 | 0 | 0 | 0 |
| Investing Cash Flow | $-443 | $866 | $-18,912 | $-35 | $-20 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -256 | N/A | -2,374 | -3,314 | -1,812 |
| Common Stock Issued | 10,023 | 1,156 | 1,740 | 2,003 | 23,685 |
| Other Financing Activity | 2,793 | 9,248 | 4,371 | -115 | -2,271 |
| Financing Cash Flow | $12,560 | $10,404 | $3,737 | $-1,426 | $19,603 |
| Beginning Cash Position | 10,747 | 2,606 | 5,202 | 21,162 | 11,742 |
| End Cash Position | 3,729 | 10,747 | 2,606 | 5,128 | 21,162 |
| Net Cash Flow | $-7,018 | $8,141 | $-2,596 | $-16,034 | $9,420 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,134 | -3,128 | 12,579 | -14,573 | -10,163 |
| Capital Expenditure | -262 | -564 | -23 | -35 | -20 |
| Free Cash Flow | -19,396 | -3,693 | 12,556 | -14,608 | -10,183 |